BDBM23299 4-amino-7-chloroquinoline (ACQ)-based compound, 4::N-{3-[bis({3-[(7-chloroquinolin-4-yl)amino]propyl})amino]propyl}-7-chloroquinolin-4-amine
SMILES: Clc1ccc2c(NCCCN(CCCNc3ccnc4cc(Cl)ccc34)CCCNc3ccnc4cc(Cl)ccc34)ccnc2c1
InChI Key: InChIKey=NEDFTNYEDKYQCR-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Botulinum Neurotoxin Type A (Clostridium botulinum) | BDBM23299 (4-amino-7-chloroquinoline (ACQ)-based compound, 4 ...) | PDB MMDB KEGG B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 3.20E+3 | n/a | n/a | n/a | n/a | 7.3 | 22 |
National Cancer Institute at Frederick | Assay Description Botox A catalyzed the hydrolysis of substrate peptide between residues 11 (glutamine) and 12 (arginine), corresponding to residues 197 and 198 of SNA... | J Med Chem 50: 2127-36 (2007) Article DOI: 10.1021/jm061446e BindingDB Entry DOI: 10.7270/Q2VQ3105 | |||||||||||
More data for this Ligand-Target Pair |